Antimicrobial resistance continues to challenge the clinical efficacy of established antibiotics, highlighting the need for innovative therapeutic strategies. Cefepime/zidebactam combines a fourth-generation cephalosporin with a novel diazabicyclooctane β-lactamase inhibitor endowed with intrinsic PBP2-targeting activity. This commentary discusses the pharmacology, mechanism of action, and medicinal chemistry of zidebactam, focusing on its distinctive peculiarities. Complementary PBP2/PBP3 targeting, together with serine β-lactamase inhibition, provides a multifaceted strategy to restore and enhance β-lactam activity against resistant pathogens.
Zidebactam as a new approved β-Lactamase inhibitor with intrinsic antibacterial activity via PBP2 binding. // Neuroretina. – 2026. – DOI: 10.1007/s00044-026-03636-0. – URL: https://link.springer.com/article/10.1007/s00044-026-03636-0
(2026). Zidebactam as a new approved β-Lactamase inhibitor with intrinsic antibacterial activity via PBP2 binding. Neuroretina. https://doi.org/10.1007/s00044-026-03636-0
“Zidebactam as a new approved β-Lactamase inhibitor with intrinsic antibacterial activity via PBP2 binding.” Neuroretina, 2026. doi:10.1007/s00044-026-03636-0.
@article{article34992,
title = {Zidebactam as a new approved β-Lactamase inhibitor with intrinsic antibacterial activity via PBP2 binding},
journal = {Neuroretina},
year = {2026},
doi = {10.1007/s00044-026-03636-0},
url = {https://link.springer.com/article/10.1007/s00044-026-03636-0}
}
Purpose The engineered v5.9 DNA polymerase has been reported to exhibit enhanced thermostability in loop-mediated isothermal amplification (LAMP). As an initial step toward field-deployable molecular diagnosis of giardiasis, we...
Background Polygenic risk scores for cardiovascular disease show poor agreement between methods, and most treat sex as a covariate rather than stratifying by it, despite well-documented sex differences in disease incidence and outcomes....
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Cognitive tests are commonly used to evaluate the effects of cognitive and exercise interventions in Parkinson’s disease, but their ability to distinguish genuine change from measurement variability remains insufficiently characterized....